The incredible speed of gene cloning and sequencing brought about by the genomic revolution has begun to outpace conventional gene discovery approaches in the pharmaceutical industry. High-throughput approaches for studying gene function in vivo are greatly needed. One potential answer to this challenge is reverse transfection, a high-throughput gene expression method for examining the function of hundreds to thousands of genes in parallel. One limitation of reverse transfection technology is the need for posttransfection processing of the arrays to analyze the activity of the expressed proteins. The authors have investigated the use of a reporter construct cotransfected with other genes of interest to monitor and screen gene function on reverse transfection microarrays. They developed a serum response element (SRE) reporter linked to the green fluorescent protein (GFP) that is cotransfected with target genes on reverse transfection arrays for monitoring mitogen-activated protein (MAP) kinase signaling by multiple targets in parallel. The authors show that this reporter system is able to detect inhibition of upstream MAP kinase signaling proteins by the MEK inhibitor U0126. The ability to monitor the activity of multiple signaling proteins in a multiwell format suggests the utility of reverse transfection reporter arrays for high-throughput screening applications. (Journal of Biomolecular Screening 2003:620-623) Key words: reverse transfection microarrays, surface-mediated transfection, serum response element (SRE) reporter construct, MAP kinase signaling proteins 620 www.sbsonline.org
INTRODUCTION
T HE NOTION OF PERFORMING SURFACE-MEDIATED transfections was first described by Palsson. 1 As contact between DNA and the target cells is a requirement for successful transfection, Palsson suggested immobilizing DNA particles onto a cell growth surface prior to attaching target cells. Subsequent addition and attachment of target cells to the DNA-loaded surface can lead to a higher probability of cell-DNA contact, potentially leading to higher transfection efficiencies. Increased transfection efficiency by concentrating DNA at the cell surface has recently been reported. 2 The appeal of performing DNA transfections off a solid surface for gene therapy applications has led to numerous reports of surfacemediated transfection using surfaces such as biodegradable poly-mers and modified silica nanoparticles. [2] [3] [4] Two groups recognized the potential of merging surface-mediated transfection technology with DNA microarray technology. Cen and Sun 5 proposed a method for simultaneously screening large numbers of genes using surface-mediated transfection of arrayed libraries of cDNAs. Immobilization of individual cDNA clones in unique locations on a surface was achieved using hybridization to arrayed oligo linkers. Simultaneous transfection of the arrayed cDNA library would thus generate patches of transfected cells that could be screened for any desired gene function using cell-based or biochemical assays.
A more straightforward immobilization approach was described by Ziauddin and Sabatini, 6 who coined the phrase "reverse transfection" to describe surface-mediated transfection of cDNAs printed by a conventional DNA arrayer. Following treatment of the array with a transfection reagent, the surface is overlaid with adherent cells, and those cells that adhere to the spots of arrayed DNA become transfected, producing localized patches of transfected cells, with each expressing a unique protein that can then be used for high-throughput analysis of gene function. The term reverse was used because the order of addition of the target cells and DNA to the surface is reversed compared to conventional transfections. One of the limitations of reverse transfection technology is the need for extensive posttransfection processing of the cell array to detect protein activity, including fixing and permeabilizing the cells and multiple antibody incubation steps. To address this issue, we developed a serum response element (SRE) reporter construct to be cotransfected with target genes on reverse transfection arrays.
MATERIALS AND METHODS

Reagents
Effectene reagent was from Qiagen (#301425). U0126 was from Cell Signaling Technology (#9903). Gelatin (#G-9391), quadriPERM cell culture vessels (#Z37,676-0), and flexiPERM Micro 12 (#Z37,666-3) devices were from Sigma. GAPS slides were from Corning (#2549). CoverWell incubation chambers were from Grace Bio-Labs (#PC200). All cell culture products were from Gibco Life Technologies.
Constructs
The pSRE-GFP vector was generated by PCR-based subcloning of the GFP gene from pQBI25-fPA (Qbiogene) into the EcoRI-AatII sites of pSRE-Luc (Stratagene). The pFC-MEKK1 vector was from Stratagene (#219086). pcDNA3-HA-KRasV12 was kindly provided by Dr. Steve Taylor (University of California, Berkeley).
Reverse transfection
Reverse transfection arrays were fabricated essentially according to the method of Ziauddin and Sabatini 6 with slight modifications. Briefly, plasmid DNAs at the indicated concentrations were mixed with gelatin (final concentration of 0.2%). DNA/gelatin solutions were printed in an array format on Corning GAPS slides using a PixSys 5500 printer (Cartesian Technologies, Irvine, CA) with a CMP10B pin (Telechem International, Inc., Sunnyvale, CA). The cytomegalovirus (CMV)-driven GFP construct pQBI25-fPA was printed at a concentration of 0.05 µg/µL. For cotransfection experiments, the optimal concentration of the pSRE-GFP vector and test vectors on reverse transfection arrays was found to be 0.10 µg/µL and 0.025 µg/µL, respectively. Effectene transfection reagent was added to a CoverWell incubation chamber, and the slide was pressed down onto the CoverWell chamber. Following a 15-to 20-min incubation, the CoverWell was peeled off the slide, and 5 to 7.5 × 10 6 HEK293 cells resuspended in 10 mL media were added to each slide within a QuadriPerm chamber. Patches of transfected cells were first detected after 16 to 24 h and were assayed after 48 to 72 h. Following fixation with 4% formaldehyde, slides were either imaged on a Zeiss Axiovert 135 fluorescence microscope or scanned on a GenePix 4000B scanner (Axon Instruments, Inc., Union City, CA) equipped with a 473-nm laser.
To fabricate reverse transfection arrays in a 96-well format, arrays of DNA/gelatin solutions were printed on a GAPS slide in a 96-well microplate footprint. The array was treated with trans-fection reagent as described above, and then the slide was converted into a well format by attaching a virtual-well Flexperm chamber with the wells over the printed arrays. HEK293 cells were added to the wells (75,000 cells/well), immediately followed by the addition of either DMSO carrier or U0126 (10 µM). For imaging, the Flexperm coverwell was carefully removed, a coverslip was placed over the area of the arrays within the wells, and the slide was imaged without fixing the cells.
RESULTS AND DISCUSSION
The SRE enhancer element is responsive to activation of multiple signaling pathways, including the mitogen-activated protein (MAP) kinase and c-Jun N-terminal kinase (JNK) pathways 7 (Fig. 1) . Incorporation of the SRE into a reporter system represents a simple and rapid means for assessing the in vivo activation of these pathways. Therefore, we coupled the green fluorescence protein (GFP) gene to the SRE enhancer element as a model system for monitoring MAP kinase signaling activity on cell transfection arrays. The resulting reporter plasmid, pSRE-GFP, was shown using conventional transfection experiments in HEK293 cells to respond to activation of the MAP kinase pathway by overexpression of several mutationally activated MAP kinase signaling proteins, including v-src, RasV12, and Raf-CAAX (data not shown).
To demonstrate the utility of this reporter system for reverse transfection arrays, microarrays of pSRE-GFP mixed with DNAs encoding for these known upstream activators of the SRE were fabricated so as to achieve cotransfection of the reporter with the activator genes of interest. To establish the position of each transfected cell cluster within the array, a border of constitutively expressed CMV promoter-driven GFP plasmid (pQBI25-fPA) spots was printed around the outside of the array. Inside this constitutive GFP border, rows of 12 replicate spots of empty pcDNA3 vector and 5 activated signaling gene constructs (v-src, SYK, RasV12, MEKK1, and Raf-CAAX) mixed with pSRE-GFP were printed. Reverse transfection was performed on the printed array by incubating with the Effectene transfection reagent and overlaying the array with HEK293 cells, as previously described. 6 After a 48-h incubation to allow for expression of the transfected proteins and activation of the SRE, the array on the slide was imaged. As shown in Figure 2 , the constitutively expressed GFP vector border spots produced clusters of between 30 and 50 cells expressing high levels of GFP protein, indicating that the reverse transfection process was successful. Patches of cells cotransfected with pSRE-GFP and the control pcDNA3 vector displayed very little GFP fluorescent signal, indicating low background SRE activation in these cells. Each of the 5 activated signaling genes generated patches of cells with a significantly higher GFP signal than the control vector, with the highest SRE activation observed with cotransfection of the activated RasV12 construct. The intensity of the GFP signal in cells transfected with the pSRE-GFP reporter, where GFP protein production is regulated by the SRE, was obviously lower than that observed in the border cell patches, where the GFP expression is driven by the strong constitutive CMV promoter. In addition, the absolute number of cells cotransfected with the SRE-GFP reporter and a second construct was somewhat lower than the number of cells transfected by the single pQBI25-fPA plasmid. Nonetheless, the GFP signal generated by gene-specific activation of the SRE promoter was easily detectable above background using both laser scanning ( Fig. 2A ) and fluorescence microscopy (Fig. 2C) . Quantitation of the level of GFP production in each cluster is shown in Figure 2B . The differences in the level of SRE activation observed by the various transfected signaling proteins may be the result of differences in the intrinsic activity of the expressed proteins or may reflect a difference in the expression levels of the different proteins. High-resolution microscope images show the effect of expression of the various signaling proteins on cell morphology (Fig. 2C) . The constitutively expressed GFP border patch cells displayed normal flat HEK293 morphology, whereas cell patches expressing the oncogene v-src appeared significantly smaller and more rounded, consistent with v-src's ability to transform mammalian cells. 8 Thus, both SRE activation status and effects on cell morphology were observed from cells in the transfected patches.
To test the efficacy of this reverse transfection reporter system for high-throughput drug-screening applications, we produced arrays of test plasmids mixed with the pSRE-GFP reporter in a 96well format. The transfection arrays within the wells were treated with the MEK inhibitor, U0126, to block signaling from upstream MAP kinase pathway activators to the SRE. Replicate spots of pSRE-GFP mixed with either control vector, the v-src construct or the Raf-CAAX construct, were printed within each well, along with replicate spots of the constitutive GFP vector for reference. Following reverse transfection, either DMSO carrier or U0126 (10 µM) was added to the wells. The arrays produced within each well were imaged without fixation after 60 h (Fig. 3) . Patches of GFPexpressing cells transfected with the constitutive GFP control plasmid, pQBI25-fPA, were present at approximately equal numbers and intensities in both the control and U0126-treated wells, in- dicating that U0126 had no obvious effect on the reverse transfection process or on cell viability. High levels of SRE activation were obtained in both the v-src and Raf-CAAX patches in the control wells, as shown by patches of GFP-expressing cells. In the U0126-treated wells, SRE activation by Raf-CAAX was completely inhibited, whereas partial inhibition was observed in the vsrc patches (Fig. 3) . Thus, the pSRE-GFP reporter successfully detected inhibition of Raf-CAAX's MAP kinase signaling activity by the U0126 compound. The residual SRE activation by v-src in the presence of U0126 may be a reflection of the stronger MAP kinase pathway activation by the upstream oncogene or may be the result of SRE activation by v-src via alternative signaling pathways. 9 In any case, a differential effect of U0126 on multiple expressed proteins was detected using the SRE-GFP reporter system. It is important to note that the reverse transfection arrays within the wells shown in Figure 3 were imaged without fixing or processing the cells. This ability to assess SRE activation by multiple targets within multiwell plates without any posttransfection processing makes this method especially suitable for high-throughput screening applications.
In summary, we have demonstrated the use of a reporter system for reverse transfection arrays for monitoring the gene function of signaling proteins. Although we have developed an SRE reporter system, this technology can easily be adapted for monitoring the activity of other signaling pathways on reverse transfection arrays, such as the cyclic AMP response element (CRE), the nuclear factor κB (NF-κB), and the nuclear factor of activated T cells (NFAT).
Such a reverse transfection reporter platform may be useful for high-throughput screening applications, both in target identification and compound screening. A permanent cell line stably expressing the reporter construct could be used to increase the target transfection efficiency and thus improve assay sensitivity. In addition, development of other reporter systems that are more quantitative than GFP and still suitable for array applications would make reverse transfection reporter systems even more attractive.
